From Exhaustion to Recovery
Jayden Donald, a 19-year-old equestrian, faced a drastic change after contracting COVID-19 twice. His once active life filled with riding and university studies was replaced by debilitating fatigue, brain fog, and physical limitations. Even walking across his house became a challenge.
Diagnosed with long COVID, Jayden's experience reflects the struggles of many patients who grapple with lingering symptoms months after the initial infection. His story highlights the need for further research and treatment options for this complex condition.
Low-Dose Naltrexone
low-dose naltrexone. Their studies suggest that this drug, typically used for opioid and alcohol dependence, can restore the function of impaired immune cells in patients with these conditions.
A Clinical Trial for Long COVID Patients
To further investigate the effectiveness of low-dose naltrexone for long COVID, the NCNED team is conducting a clinical trial involving 100 patients across Australia. Half will receive the drug, while the other half will receive a placebo. Researchers will then compare the results with a control group of 50 healthy individuals.
A Hopeful Future for Jayden and Others
While Jayden's recovery journey continues, he has made significant progress with the help of low-dose naltrexone and other treatments. He has returned to university and even started riding again, gradually increasing his time in the saddle.
Jayden's story offers hope for others battling long COVID. The ongoing research and clinical trials hold promise for developing effective treatments and improving the lives of patients like him.